Investor Update: Cello Health puts in strong first half performance

Top stories from the Proactive Investors UK newsroom.

Healthcare marketing group Cello Health (LON:CLL) has reported a strong first six months of the year, with good like-for-like growth in overall net revenues and headline profit before tax. Margins have also improved and this year’s results will at least be in line with current market expectations.

Minds + Machines (LON:MMX) has also seen healthy revenue growth with domain name registrations up 19% to 1.82mln. Sales of the group’s original 28 domains rose by 30%.

OptiBiotix (LON:OPTI) has signed a distribution agreement with BioEnergiser that will see its SlimBiome Medical weight loss supplements sold online in the UK. Today’s deal gives BioEnergiser the right to distribute the supplements online within the UK, whilst still allowing Opti to continue to sell its product on its own online store.

Online fashion retailer ASOS has warned sales growth is being held back by  problems in the US with its new warehouse. Sales in the four months rose by 12% but ASOS says the US problem will continue for the rest of the year and is scaling back expectations accordingly. 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



PCF Bank's Scott Maybury reports on strong lending growth and increased...

PCF Group Plc's (LON:PCF) Scott Maybury speaks to Proactive London's Andrew Scott after the specialist lender posted record numbers in its latest year. Loans outstanding rose 55% to £339mln with profits for the twelve months to September climbing by 54% to £8mln. Maybury says targets for a...

9 hours, 32 minutes ago

2 min read